The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas

• Published in: Cancers Vol. 9; no. 7; p. 85
• Main Authors: Beyer, Sasha, Fleming, Jessica, Meng, Wei, Singh, Rajbir, Haque, S Jaharul, Chakravarti, Arnab
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 10-07-2017; MDPI
• Subjects: Angiogenesis; Biomarkers; Gene expression; Gene regulation; Gene silencing; Glioma; Metabolism; miRNA; Non-coding RNA; Post-transcription; Review; Therapeutic applications; Tumorigenesis; glioma; miRNA; cell metabolism; glioblastoma; invasion; angiogenesis
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers9070085

MicroRNAs (miRNAs) are small, non-coding, endogenous RNA molecules that function in gene silencing by post-transcriptional regulation of gene expression. The dysregulation of miRNA plays a pivotal role in cancer tumorigenesis, including the development and progression of gliomas. Their small size, stability and ability to target multiple oncogenes have simultaneously distinguished miRNAs as attractive candidates for biomarkers and novel therapeutic targets for glioma patients. In this review, we summarize the most frequently cited miRNAs known to contribute to gliomagenesis and progression by regulating the defining hallmarks of gliomas, including angiogenesis, invasion, and cell metabolism. We also discuss their promising potential as prognostic and predictive biomarkers and novel therapeutic targets, in addition to the challenges that must be overcome before their translation from bench to bedside.